Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study

BACKGROUND: The phase III COntinuous or INtermittent (COIN) trial failed to show non-inferiority of intermittent compared with continuous chemotherapy for advanced colorectal cancer in overall survival (OS). The present analysis evaluated whether the derived neutrophil to lymphocyte ratio (dNLR) cou...

Descripción completa

Detalles Bibliográficos
Autores principales: Grenader, Tal, Nash, Stephen, Adams, Richard, Kaplan, Richard, Fisher, David, Maughan, Tim, Bridgewater, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800295/
https://www.ncbi.nlm.nih.gov/pubmed/26889974
http://dx.doi.org/10.1038/bjc.2016.23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4800295/
https://www.ncbi.nlm.nih.gov/pubmed/26889974
http://dx.doi.org/10.1038/bjc.2016.23

Ejemplares similares